These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16612053)

  • 21. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bioavailability of two brands of ciprofloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gender on the pharmacokinetics of ofloxacin.
    Sowinski KM; Abel SR; Clark WR; Mueller BA
    Pharmacotherapy; 1999 Apr; 19(4):442-6. PubMed ID: 10212016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy.
    Gattis WA; Petros WP; Pickard WW; Drew RH; May DB; Hathorn JW
    Pharmacotherapy; 1997; 17(4):836-40. PubMed ID: 9250569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
    Chyrek-Borowska S; Siergiejko Z; Michalska I; Szymański W
    Pneumonol Alergol Pol; 1992; 60(1-2):36-9. PubMed ID: 1290977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion.
    Png JC; Tan E; Foo KT; Li MK; Cheng C; Rekhraj IR
    Br J Urol; 1997 May; 79(5):781-4. PubMed ID: 9158519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 31. Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination.
    Bulitta JB; Kinzig M; Naber CK; Wagenlehner FM; Sauber C; Landersdorfer CB; Sörgel F; Naber KG
    Chemotherapy; 2011; 57(5):402-16. PubMed ID: 22024700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dose on the distribution kinetics of ciprofloxacin and ofloxacin in the isolated hindlimb of the rat.
    Casquero-Dorado AC; Colino CI; Martínez MS; Sánchez-Navarro A
    Biopharm Drug Dispos; 2000 Nov; 21(8):313-9. PubMed ID: 11514950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.
    Mueller BA; Brierton DG; Abel SR; Bowman L
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2101-5. PubMed ID: 7811026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution.
    Colino CI; García Turiño A; Sanchez Navarro A; Lanao JM
    Biopharm Drug Dispos; 1998 Mar; 19(2):71-7. PubMed ID: 9580344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ciprofloxacin.
    Bergan T; Dalhoff A; Rohwedder R
    Infection; 1988; 16 Suppl 1():S3-13. PubMed ID: 3286512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.
    Berger SA; Yavetz H; Paz G; Gorea A; Homonnai Z
    J Urol; 1990 Sep; 144(3):683-4. PubMed ID: 2388328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of gender effect on ciprofloxacin pharmacokinetics in humans.
    Gallicano K; Sahai J
    Br J Clin Pharmacol; 1996 Nov; 42(5):632-4. PubMed ID: 8951196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.
    Chien SC; Chow AT; Natarajan J; Williams RR; Wong FA; Rogge MC; Nayak RK
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1562-5. PubMed ID: 9210685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.